Considerations for the programming of an open-loop insulin infusion device from the biostator glucose controller

Area of Science:

• Endocrinology
• Biomedical Engineering
• Metabolic Diseases

Background:

• Diabetes management requires precise insulin delivery.
• Open-loop insulin pumps offer preprogrammed delivery but lack real-time glucose sensing.
• The Biostator Glucose Controller can generate insulin flow rates for pump programming.

Purpose of the Study:

• To evaluate the feasibility of preprogramming an open-loop insulin device with Biostator-generated insulin rates.
• To compare meal-related glycemic patterns under Biostator control in diabetic patients.
• To assess the effectiveness of preprogrammed insulin delivery for achieving normal glucose levels.

Main Methods:

• 10 juvenile-onset diabetic patients underwent 24-h Biostator glucose control.
• Comparisons were made for meals of identical size/composition at different times and on consecutive days.
• 4 additional patients had 72-h Biostator control.
• Insulin infusion rates were preprogrammed based on Biostator data.

Main Results:

• Meal-related glycemic patterns (MIME) were consistent for identical meals within a day and across consecutive days.
• Preprogrammed open-loop delivery showed encouraging but preliminary results.
• The subcutaneous route demonstrated delayed insulin absorption, impacting glucose level normalization.

Conclusions:

• Biostator-generated insulin profiles can create similar glycemic patterns for standardized meals.
• Preprogramming open-loop devices is feasible but faces limitations.
• Delayed insulin absorption via subcutaneous injection hinders optimal glucose control with current open-loop systems.